Related Experiment Video
Updated: Sep 7, 2026

An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment
Published on: December 3, 2020
Points to be considered for conducting toxicokinetic studies under GLP and for validating analytical methods
T Yuzuriha1, K Aizawa, J Okada
1Pharmaceutical Regulatory Audit & Compliance Department, Eisai Co., Ltd, Tokyo, Japan.
Abstract:
Issues discussed by TK Working Group of the JPMA for the implementation of ICH guideline for toxicokinetics (TK) are summarized. 1) A unique management system may be needed for toxicokinetic studies, when TK measurements are conducted in a center for pharmacokinetics and metabolism studies, i.e. in a separate location or by an independent organization from those for toxicity studies. 2) TK measurement should be conducted in compliance with the protocols and validated SOPs for analytical methods. 3) Every time when study conditions in toxicity studies and/or TK measurement are changed, the analytical method should be more or less revalidated. The present paper will discuss some practical issues to be involved in such situations, and possible countermeasures for them.
More Related Videos
14:34A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English
Published on: April 3, 2026
10:24Identification of Potential Anti-TB Candidates: A Step-by-Step Guide to Synthesis, MIC Determination, and Cytotoxicity Assessment in Mammalian Cells
Published on: May 22, 2026
Related Concept Videos
Bioavailability Study Design: Healthy Subjects Versus Patients
Measurement of Bioavailability: Pharmacodynamic Methods
Clinically Relevant Drug Product Specifications: Methods of Establishment
Therapeutic Drug Monitoring: Drug Analysis Methods
Toxicokinetics: Overview
Toxicity Testing in Animals